Advertisement

  

Medical News

Hepatitis Drug's New Name: Incivek

From U.S. Centers for Disease Control and Prevention

May 5, 2011

Vertex Pharmaceuticals Inc.'s hepatitis C drug telaprevir, which won the endorsement last week of an expert panel of Food and Drug Administration advisers, has been given its brand name: Incivek (pronounced in-see-veck). FDA's decision on whether to grant final approval of the drug is expected May 23.

Back to other news for May 2011

Adapted from:
Boston Globe
05.04.2011; Robert Weisman




  
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
 
See Also
Why Incivek and Victrelis Herald a New Era in Hepatitis C Treatment
Q&A on Hepatitis C and African Americans With Jonathan McCone, M.D., Victrelis Researcher
FDA Approves Victrelis (Bocepravir) for Hepatitis C
The Fair Pricing Coalition Expresses Dismay at the Price of Merck's Newly Approved Hepatitis C Drug
No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement
Advertisement